Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Creative Hub is a fast-growing cloud software platform for creative people to store, share files, and collaborate on projects. The collaboration tools also allow users to chat in real-time, and add comments on images, allowing creative teams to work faster and deliver better results. Creative Hub enables users to order professional art & photographic prints, or physical 3D prints, which are produced at its print production facilities in London(UK) and Dusseldorf (Germany). The platform currently has 40,000 active users which are growing day by day. With the investment, the company will drive growth through marketing and launch its New York production facility.
days to go:
Expired
investment:
£286,992
StarStock are a drinks marketplace that enable suppliers to sell direct to wholesalers, pubs, shops, bars & restaurants nationwide. StarStock puts the suppliers in control of their products and listings, taking a small percentage of each sale. Suppliers set the prices, while we do the rest, arranging delivery of beers, ciders, wine and spirits.
days to go:
Expired
investment:
£1,343,149
Whey Forward Health make innovative health and nutrition products. Since the launch in 2013 they have sold over 350,000 products. Promixx an original vortex mixer, battery powered, self-stirring protein shake maker, being their first product which is now sold in over 50 countries. They are now looking to launch two new shakes Regenerative and Morning Glory which are repeat purchase products. The investment will create two new websites operating on a subscription model and help them unlock their growth potential.
days to go:
Expired
investment:
£292,399
Drop Bear Beer Co. aims in disrupting and exciting the alcohol-free beer market. It is the only female-run alcohol-free craft beer company. Drop Bear Beer Co.'s May 2019 launch was a success as it experienced sales of 3000 units in one month. The company is a winner of the Wales Start-Up of the Year Awards 2019. With the proceeds, Drop Bear Beer Co. will finalise core range within 12 months, scale-up production, make range available in cans, and arrange a large brand-building campaign.
days to go:
Expired
investment:
£172,570
East London Liquor Company export from east London to 20 countries worldwide. They have plans to launch in Ibiza, Toronto, Los angles, New York and Shanghai. They also own their own restaurant. Since 2014 they have grown there team from 4 to 30 people. London dry gin has won many award and the East London Liquor Company produces over 12,000 bottles of gin a month.
days to go:
Expired
investment:
£1,326,450
